Lastly question too the long term holders. hopper has put it on record that the biotechs don’t usually go past phase 2 as it’s expensive. Do most biotechs that have drugs like ptx that has its own in a 1b/2A trial get sold off. ?
just wondering how many hopefuls get bought out ?
